The Latest Cardiac and Vascular News
SANTA CRUZ, Calif., May 9, 2023 /PRNewswire/ — Emboline, Inc., a privately held medical technology company focused on reducing stroke during structural heart procedures such as transcatheter aortic valve replacement (TAVR), today announced the first patient has been treated in the Protect […]
Financing led by Matrix Capital Management with significant investment from an undisclosed strategic investor — Eric Xiao of Matrix Capital Management to join the Emboline Board of Directors SANTA CRUZ, Calif., May 25, 2021 /PRNewswire/ — Emboline, Inc., a privately held medical device […]
In the SafePass 2 clinical study, the Emboliner™ demonstrated excellent safety and technical performance, and captured five times more debris than commercially-available devices SANTA CRUZ, Calif., Jan. 5, 2021 /PRNewswire/ — Emboline, Inc., a privately held medical technology company focused on reducing stroke […]
SANTA CRUZ, Calif.–(BUSINESS WIRE)–Emboline™, Inc., developer of embolic protection technology for brain and body during transcatheter aortic valve replacement (TAVR), today announced the closing of a $5 million bridge round of financing from a number of existing and new investors. […]
Early Results from First 24 Patients Show Excellent Safety Profile and Technical Performance, with Significant Debris Capture and Removal in All Patients SANTA CRUZ, Calif.–(BUSINESS WIRE)–Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), today […]
SANTA CRUZ, Calif., June 5, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today the successful completion of its initial series of human clinical cases using […]
SANTA CRUZ, Calif., April 19, 2018 /PRNewswire/ — Emboline, Inc., an emerging medical device company with a game-changing device for total embolic protection during transcatheter aortic valve replacement (TAVR) procedures, announced today that it has completed a Series B funding round totaling […]
